Member Contact: Vanessa Villard
Position: Chief Executive Officer
Industry: Biotech & Pharmaceuticals
Amylgen is a preclinical CRO offering in vivo models of psyhiatric and neurodegenerative diseases. By combining a strong experience in behavior with expertise in biochemistry, neurochemistry and histology, Amylgen offers an integrated service. Your product can be evaluated on multiple aspects of brain function including memory, depression, anxiety.
All behavior effects may be supported by relevant analysis helping the understanding of the mechanism of action on brain health.